Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Takeda Pharmaceutical Li...

    NYSE: TAK · Real-Time Price · USD
    14.97
    0.17 (1.15%)
    At close: Aug 15, 2025, 9:58 AM

    Takeda Pharmaceutical Cash Flow Statement

    Financials in JPY. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
    Net Income
    		 107.93B 144.07B 317.04B 230.17B
    Depreciation & Amortization
    		 761.4B 728B 664.4B 583.15B
    Stock-Based Compensation
    		 72.87B 70.87B 60.67B 43.37B
    Other Working Capital
    		 41.68B -145.47B 31.9B -58.09B
    Other Non-Cash Items
    		 167.25B 120.81B -97.74B 95.4B
    Deferred Income Tax
    		 n/a -91.41B 58.05B 72.41B
    Change in Working Capital
    		 -52.25B -256B -25.26B 98.61B
    Operating Cash Flow
    		 1,057.2B 716.34B 977.16B 1,123.1B
    Capital Expenditures
    		 -200.79B -480.73B -633.69B -186.04B
    Cash Acquisitions
    		 n/a -4.74B 7.96B -21.48B
    Purchase of Investments
    		 n/a -40.07B -10.15B -8.34B
    Sales Maturities Of Investments
    		 n/a 8.02B 22.25B 16.92B
    Other Investing Acitivies
    		 -166.26B -251.66B 6.53B 808M
    Investing Cash Flow
    		 -367.06B -463.86B -607.1B -198.13B
    Debt Repayment
    		 -341.8B 1.51B -325.07B -600.48B
    Common Stock Repurchased
    		 -51.86B -2.33B -26.93B -77.53B
    Dividend Paid
    		 -302.5B -287.19B -279.42B -283.67B
    Other Financial Acitivies
    		 -55.26B -66.42B -77.73B -108.59B
    Financial Cash Flow
    		 -751.42B -354.42B -709.15B -1,070.3B
    Net Cash Flow
    		 -72.69B -75.73B -316.17B -116.53B
    Free Cash Flow
    		 856.39B 235.61B 343.47B 937.07B

    Add to Watchlist